BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10559556)

  • 1. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
    Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
    Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus.
    Dubelaar EJ; Verwer RW; Hofman MA; Van Heerikhuize JJ; Ravid R; Swaab DE
    J Neuropathol Exp Neurol; 2004 Feb; 63(2):159-69. PubMed ID: 14989602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.
    Stern Y; Brandt J; Albert M; Jacobs DM; Liu X; Bell K; Marder K; Sano M; Albert S; Del-Castillo Castenada C; Bylsma F; Tycko B; Mayeux R
    Ann Neurol; 1997 May; 41(5):615-20. PubMed ID: 9153523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished neuronal metabolic activity in Alzheimer's disease. Review article.
    Salehi A; Swaab DF
    J Neural Transm (Vienna); 1999; 106(9-10):955-86. PubMed ID: 10599878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.
    Hesse C; Bogdanovic N; Davidsson P; Blennow K
    Dement Geriatr Cogn Disord; 1999; 10(6):452-9. PubMed ID: 10559559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
    Singleton AB; Wharton A; O'Brien KK; Walker MP; McKeith IG; Ballard CG; O'Brien J; Perry RH; Ince PG; Edwardson JA; Morris CM
    Dement Geriatr Cogn Disord; 2002; 14(4):167-75. PubMed ID: 12411758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.
    Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
    Dement Geriatr Cogn Disord; 1999; 10(4):252-7. PubMed ID: 10364641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.
    Ghebremedhin E; Schultz C; Braak E; Braak H
    Exp Neurol; 1998 Sep; 153(1):152-5. PubMed ID: 9743577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE, vascular pathology, and the AD brain.
    Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
    Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ detection of apolipoprotein E epsilon 4 in archival human brain.
    Saito Y; Ruberu NN; Harada M; Arai T; Sawabe M; Nukina N; Murayama S
    Neuroreport; 2004 May; 15(7):1113-5. PubMed ID: 15129156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.
    Zarow C; Lyness SA; Mortimer JA; Chui HC
    Arch Neurol; 2003 Mar; 60(3):337-41. PubMed ID: 12633144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.
    Arendt T; Schindler C; Brückner MK; Eschrich K; Bigl V; Zedlick D; Marcova L
    J Neurosci; 1997 Jan; 17(2):516-29. PubMed ID: 8987775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
    Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
    Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
    Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
    Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.